Direct-to-consumer prescription drug advertising: A study of consumer attitudes and behavioral intentions

Journal of Consumer Marketing

Volumn 22, Issue 7, 2005, Pages 369-378

  Singh, Tanuja ^a   Smith, Donnavieve ^a  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

Advertising; Consumer behaviour; Medical prescriptions; Pharmaceutical products; Promotional methods

Indexed keywords

EID: 28844456908     PISSN: 07363761     EISSN: None     Source Type: Journal    
DOI: 10.1108/07363760510631101     Document Type: Article

References (29)

1. Alleyne, S. (2002), "Commercial medicine", Black Enterprise, Vol. 33 No. 1, pp. 107-8.
2. Ajzen, I. and Fishbein, M. (1977), "Attitude behavior relations: a theoretical analysis and review of empirical research", Psychological Bulletin, pp. 888-918.
3. Anderson, P.J. (2003), "Study measures DTC impact", Pharmaceutical Executive, Vol. 23 No. 8, p. 18.
4. Ausness, R.C. (2002), "Will more aggressive marketing practices lead to greater tort liability for prescription drug manufacturers?", Wake Forest Law Review, Vol. 37 No. 1, pp. 97-139.
5. Biehal, G., Stephens, D. and Curlo, E. (1992), "Attitude toward the ad and brand choice", Journal of Advertising, Vol. 21 No. 3, pp. 19-36.
6. Burton, S. and Lichtenstein, D.R. (1988), "The effect of ad claims and ad context on attitude toward the advertisement", Journal of Advertising, Vol. 17 No. 1, pp. 3-11.
7. Calfee, J.E. (2002), "Public policy issues in direct-to-consumer advertising of prescription drugs", Journal of Public Policy and Marketing, Vol. 21, Fall, pp. 174-93.
8. Chandra, A. and Holt, G.A. (1999), "Pharmaceutical advertisements: how they deceive patients", Journal of Business Ethics, Vol. 18, pp. 359-66.
9. Coney, S. (2002), "Direct-to-consumer advertising of prescription pharmaceuticals: a consumer perspective from New Zealand", Journal of Public Policy and Marketing, Vol. 21 No. 2, pp. 213-23.
10. Dukes, D.E., Rogers, J. and Paine, E.A. (2001), "What you should know about direct to consumer advertising of prescription drugs", Defense Counsel Journal, Vol. 58 No. 1, pp. 36-49.
11. Eagle, L. and Kitchen, P. (2002), "Direct consumer promotion of prescription drugs: a review of the literature and the New Zealand experience", International Journal of Medical Marketing, Vol. 2 No. 4, pp. 293-310.
12. Elliott, S. (2002), "Pharmaceutical makers and ad agencies fight to preserve campaigns for prescription drugs", The New York Times, July 12, p. 2.
13. Findlay, S. (2002), "Do ads really drive pharmaceutical sales?", Marketing Health Services, available at: web.lexis-nexis.com/universe (accessed October 17, 2003).
14. Friedwald, V. Jr (2000), "The internet's influence on the doctor-patient relationship", Health Management Technology, Vol. 21 No. 11, p. 80.
15. Hair, J.E., Anderson, R., Tatham, R. and Black, W. (1998), Multivariate Data Analysis, Prentice Hall, Englewood Cliffs, NJ.
16. Iyengar, S.S. and Leppar, M.L. (2000), "Personality processes and individual differences when choice is demotivating: can one desire too much of a good thing?", Journal of Personality and Social Psychology, Vol. 79 No. 6, pp. 995-1006.
17. Kaiser Family Foundation (2003), "Impact of direct-to-consumer advertising on prescription drug spending," available at: www.kff.org/ rxdrugs/6084-index.cfm (accessed November 29, 2003).
18. Kreps, D.M. (1979), "A representation theorem for preference for flexibility", Econometrica, Vol. 47, pp. 565-77.
19. Krisanits, T. (2003), "DTC grows drug class, not brand share", Medical Marketing and Media, Vol. 38 No. 12, p. 26.
20. Lexchin, J. and Mintzes, B. (2002), "Direct-to-consumer advertising of prescription drugs: the evidence says no", Journal of Public Policy and Marketing, Vol. 21, Fall, pp. 194-201.
21. Reast, J.D., Palihawadana, D. and Spickett-Jones, G. (2004), "UK Physicians' attitudes towards direct-to-consumer prescription drugs: an extension and review", International Journal of Advertising, Vol. 23, pp. 229-51.
22. Schroff, K. (2003), "Why pharma branding doesn't work", Pharmaceutical Executive, Vol. 23 No. 10, pp. 50-8.
23. Shankland, S. (2003), "To DTC or not to DTC? Direct to consumer advertising can seem like a prescription for futility", Marketing Health Services, Winter, Winter, p. 44.
24. Smith, D. (1998), "We hold the keys and we know it", Pharmaceutical Executive DTC Times Supplement, May, pp. 8-9.
25. Steiner, I.D. (1970), "Perceived freedom", in Berkowitz, L. (Ed.), Advances in Experimental Social Psychology, Academic Press, New York, NY, pp. 187-248.
26. Wathieu, L., Brenner, L., Carmon, Z., Chattopadhyay, A., Wertenbroch, K., Droleet, A., Gourville, J., Muthukrishnan, A.V., Novemsky, N., Ratner, R.K. and Wu, G. (2002), "Consumer control and empowerment", Marketing Letters, Vol. 13 No. 3, pp. 297-305.
27. Wealleans, S. (2003), "DTC could use a fresh injection of strategy", Medical Marketing and Media, Vol. 38 No. 12, p. 98.
28. Wilkes, M., Bell, R.A. and Kravitz, R.L. (2000), "Direct to consumer prescription drug advertising: trends, impact, and implications", Health Affairs, Vol. 19 No. 2, pp. 110-28.
29. Yuan, Y. and Duckwitz, N. (2002), "Doctors and DTC", Pharmaceutical Executive, Vol. 22 No. 9, pp. 114-24.